MedKoo Cat#: 573298 | Name: Guacetisal

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Guacetisal is an antitussive and analgesic tolerated by patients with aspirin-asthma. It may be used in the treatment of bronchial inflammatory disorders and chronic obstructive bronchopneumopathy.

Chemical Structure

Guacetisal
Guacetisal
CAS#55482-89-8

Theoretical Analysis

MedKoo Cat#: 573298

Name: Guacetisal

CAS#: 55482-89-8

Chemical Formula: C16H14O5

Exact Mass: 286.0841

Molecular Weight: 286.28

Elemental Analysis: C, 67.13; H, 4.93; O, 27.94

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Aspirin guaiacol ester, Broncaspin, Guacetisal
IUPAC/Chemical Name
Benzoic acid, 2-(acetyloxy)-, 2-methoxyphenyl ester
InChi Key
HSJFYRYGGKLQBT-UHFFFAOYSA-N
InChi Code
1S/C16H14O5/c1-11(17)20-13-8-4-3-7-12(13)16(18)21-15-10-6-5-9-14(15)19-2/h3-10H,1-2H3
SMILES Code
c1ccc(c(c1)OC(=O)C)C(=O)Oc1c(cccc1)OC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 286.28 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Zanierato G, Ranghino E, Negri L, Morandini GC. [Treatment of bronchial inflammatory disorders with guacetisal]. Minerva Med. 1981 Feb 28;72(7):443-9. Italian. PubMed PMID: 7017496. 2: Cerqua R, Trovello C, Infante G, Ricciardi S. [The use of guacetisal in chronic obstructive bronchopneumopathy. Controlled clinical study]. Minerva Med. 1981 Feb 28;72(7):355-62. Italian. PubMed PMID: 7017485. 3: Carpinteri F, Carosi M. [Guacetisal in the treatment of acute and chronic bronchopneumopathy]. Minerva Med. 1981 Feb 28;72(7):347-53. Italian. PubMed PMID: 7017484.